Clinical Ink is a technology company that provides e-source solutions. It develops GlucoseReady, a digital platform designed for transforming cardiometabolic clinical trials, and utilizes the SPUR behavioral assessment tool and predictive analytics to maintain patient engagement and dropout rates. The company caters to pharmaceutical, medical device, and academic institutions.